Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Brainify.AI

Full‑stack precision‑medicine neurotech platform: Foundational model, multimodal dataset, EEG hardware
2021
Nov-50
11-50
New York, New York, United States
No tags found for this post.

Innovation

Industry Problem

Psychiatric treatment often relies on trial-and-error prescribing because biological differences between patients are not routinely used to select therapy.

R&D Focus

Biomarker-guided neuropsychiatric drug development

Innovative Solution

Brainify.AI is a full-stack EEG neurotech platform. Our full-stack precision-medicine neurotech platform-five integrated assets: Foundational AI model(developed in-house), multimodal EEG dataset (largest of its king), EEG hardware system (small, portable), Companion Diagnostics (engine to stratify patients), Drag rescue (revive shelved CNS assets).

Investment Funding

Last Funding Stage

Pre-Seed

Total Funding Amount

1.75M

Last Funding Amount

150.K

Last Funding Date

01-10-2023

Startup Stage

Seed

Lead Investors

Merck Digital Sciences Studio

People

Founders

About

Brainify.AI is a full-stack EEG neurotech platform. Our mission is to decode the brain and bring precision medicine to billions of people suffering from psychiatric, neurological, and neurodegenerative disorders. > 100 M U.S. Americans per year face brain disorders with almost zero objective biomarkers. Lack of brain biology knowledge, data & heavy reliance on subjective assessments present major challenge in treating brain disorders. Our full‑stack precision‑medicine neurotech platform—five integrated assets: Foundational AI model(developed in-house), multimodal EEG dataset (largest of its king), EEG hardware system (small, portable), Companion Diagnostics (engine to stratify patients), Drag rescue (revive shelved CNS assets).

Something missing or incorrect on this page? Help us enrich this information